Growing evidence suggests that when GPX4 is inactivated, FSP1 can continue to maintain tumor growth in vivo, while deletion of GPX4 and FSP1 can inhibit tumor growth (Doll et al., 2019). This evidence concerns the gene GPX4 and neoplasm.